Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Patents
  • Published:

Taking the profit out of biomedical research tools

Nature Biotechnology volume 17, pages 819–820 (1999)Cite this article

Abstract

A National Institutes of Health proposal will restrict the licensing of Federally funded biomedical research tools for commercial gain.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Marshall, E. Science 278, 212–213 (1997); Adler, R.G. The New Biologist 2, 495–497 (1990).

    Article  CAS  Google Scholar 

  2. 35 USC §§ 200 et seq.

  3. Intellectual Property Rights and Research Tools in Molecular Biology. Summary of a study held at the National Academy of Sciences, Feb. 15–16, 1996.

  4. Report of the NIH Working Group on Research Tools, p. 4, June 4, 1998.

  5. See Eisenberg, R. 5 Risk: Health Safety & Environment 163 (1994). Professor Eisenberg has also argued in favor of a research exemption from the patent laws. See Eisenberg, R. 56 U. Chi. L. Rev. 1017 (1989).

    Google Scholar 

  6. See NIH Proposed Guidelines for Recipients of NIH Research Grants and Contracts on Obtaining and Disseminating Biomedical Research Resources; Request for Comments, 64 Fed. Reg., No. 100, May 25, 1999, pp. 28205–28209.

  7. Id. at 28206.

  8. Id.

  9. Id. at 28205, fn.1.

  10. Id.

  11. Id. at 28207.

  12. Id.

  13. Id. at 28206.

  14. Id.

  15. National Academy Study, Chapter 5, Case Studies, "Protein and DNA sequencing instruments: Research tools to which strong patent protection promoted broad access.".

  16. Id.

  17. Id.

  18. Undocumented conversation with Dr. Leroy Hood .

  19. 35 USC § 203.

  20. 35 USC § 203(1)(a) through (d).

  21. 35 USC § 202(a)(ii).

Download references

Author information

Authors and Affiliations

  1. partner at Campbell & Flores LLP, 4370 La Jolla Village Drive, Suite 700, San Diego, 92122, CA

    Mauricio A. Flores

Authors
  1. Mauricio A. Flores
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Flores, M. Taking the profit out of biomedical research tools. Nat Biotechnol 17, 819–820 (1999). https://doi.org/10.1038/11774

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/11774

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing